Urgent.News

What's breaking now, across thousands of outlets.

Editions

Health & Medicine

First Therapy Approved for Dangerous Metabolic Disorder

(MedPage Today) -- The FDA on Wednesday granted accelerated approval to pariglasgene brecaparvovec (Genglycos) as the first treatment for glycogen storage disease type Ia (GSDIa), an inherited metabolic disorder that requires frequent consumption...

First Therapy Approved for Dangerous Metabolic Disorder

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Thursday 20 August →